Takeda Announces Significant Job Cuts, Centered on Cambridge R&D
Takeda's Zasocitinib Shows Promising Phase III Results for Psoriasis, Signaling a Potential Breakthrough
Takeda and Nabla Bio Forge $1 Billion Alliance to Revolutionize Antibody Design with AI
Massachusetts' Biopharma Giant, Takeda, Announces Significant Layoffs Impacting 137 Employees in Cambridge Amidst Industry Restructuring